Use of live cold-adapted influenza A H1N1 and H3N2 virus vaccines in seropositive adults
about
A Tool for Investigating Asthma and COPD Exacerbations: A Newly Manufactured and Well Characterised GMP Wild-Type Human Rhinovirus for Use in the Human Viral Challenge ModelQuantitative review of antibody response to inactivated seasonal influenza vaccines.The human side of influenza.Evaluating a surrogate endpoint at three levels, with application to vaccine development.In elderly persons live attenuated influenza A virus vaccines do not offer an advantage over inactivated virus vaccine in inducing serum or secretory antibodies or local immunologic memory
P2860
Use of live cold-adapted influenza A H1N1 and H3N2 virus vaccines in seropositive adults
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 1990
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Use of live cold-adapted influenza A H1N1 and H3N2 virus vaccines in seropositive adults
@en
Use of live cold-adapted influenza A H1N1 and H3N2 virus vaccines in seropositive adults.
@nl
type
label
Use of live cold-adapted influenza A H1N1 and H3N2 virus vaccines in seropositive adults
@en
Use of live cold-adapted influenza A H1N1 and H3N2 virus vaccines in seropositive adults.
@nl
prefLabel
Use of live cold-adapted influenza A H1N1 and H3N2 virus vaccines in seropositive adults
@en
Use of live cold-adapted influenza A H1N1 and H3N2 virus vaccines in seropositive adults.
@nl
P2093
P2860
P1476
Use of live cold-adapted influenza A H1N1 and H3N2 virus vaccines in seropositive adults
@en
P2093
P2860
P304
P407
P577
1990-03-01T00:00:00Z